ACTUATE THERAPEUTICS, INC.
Insider activity for last month from Oct 16 to Nov 16.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
ACTU transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|
Thomson Todd SDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | —View disclosure → | |
Thomson Todd SDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | —View disclosure → | |
Thomson Todd SDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | —View disclosure → | |
Thomson Todd SDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | —View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund III, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund I, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund I, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → | |
BIOS Fund I, LPDirectorDIR | GrantForm 4 code A. Grant, award, or other acquisition under Rule 16b-3(d). | $0View disclosure → |
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Nov 2, 2026
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Oct 2026 | 0 | 0 | 30 | $0 | $0 | $0 |
| Nov 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (20)Largest insider activity
By absolute net disclosed value · current transaction page- BL$0
- BL$0
- TS—
Filing, role and holdings details
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period- A · Grants / awards · dominant30 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesReported Holdings After
Separated by insider, security, and ownership type
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redACTUATE THERAPEUTICS, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at ACTUATE THERAPEUTICS, INC.?
DEMETRIADES JAMES T, Kairos-Actuate SPV, L.P., Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., THOMSON TODD S, BIOS Fund III, LP, BIOS Fund III NT, LP, BIOS Fund III QP, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.